White label – Pompe disease - ClinicalTrials.eu

Study on Blood Pressure Management with Urapidil, Phenylephrine, and Labetalol for Patients with Acute Ischemic Stroke After Endovascular Therapy

Not recruiting

3 1 1 1
Investigated Diseases:
- Ischaemic stroke
Investigated Drugs:
Evaluating the effects of intravenous melatonin for preventing agitation and emergence delirium in children undergoing elective surgery

Not recruiting

3 1 1
Investigated Drugs:
- Melatonin
- Sodium Chloride
Safety and efficacy study of RTX001 autologous macrophage therapy in patients with decompensated liver cirrhosis

Not recruiting

1 1 1 1
Investigated Diseases:
- Hepatic cirrhosis
Investigated Drugs:
- Rtx001
- Filgrastim
Study on Napabucasin with FOLFIRI for Adults with Metastatic Colorectal Cancer After Standard Treatments

Not recruiting

3 1 1 1
Investigated Diseases:
- Colorectal cancer metastatic
Investigated Drugs:
Study on the Safety and Effectiveness of Atezolizumab with Thiopurine Therapy for Patients with Advanced or Metastatic Solid Tumors

Not recruiting

2 1 1 1
Investigated Drugs:
- Tioguanine
- Atezolizumab
Study on the Safety of Allogeneic Adipose Tissue-Derived Mesenchymal Stromal Cells for Patients with Epidermolysis Bullosa

Not recruiting

1 1 1
Investigated Diseases:
- Epidermolysis bullosa
Investigated Drugs:
- Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells Expanded
Study on the Effects of ALZ-801 in Patients Aged 50-80 with Early Alzheimer’s Disease and APOE4 Genotype

Not recruiting

2 1 1
Investigated Diseases:
- Dementia Alzheimer’s type
Investigated Drugs:
- Valiltramiprosate
Study Comparing Weekly Low Dose Cisplatin to High Dose Every Three Weeks for Sarcopenic Patients with Head and Neck Cancer

Not recruiting

3 1 1 1
Investigated Diseases:
- Squamous cell carcinoma of head and neck
Investigated Drugs:
- Cisplatin
Study on the Effects and Safety of ZYN002 Gel for Children, Adolescents, and Young Adults with Fragile X Syndrome

Not recruiting

3 1
Investigated Diseases:
- Fragile X syndrome
Investigated Drugs:
- Cannabidiol
Study of Rituximab, Polatuzumab Vedotin, and Glofitamab for Untreated Aggressive B-cell Lymphoma in Patients Over 60 Not Eligible for Full R-CHOP

Not recruiting

2 1 1 1
Investigated Diseases:
- B-cell lymphoma
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies